AutoICD API

P04.1A

Billable

Newborn affected by maternal use of anxiolytics

Newborn affected by maternal use of anxiolytics

Status

Billable / Specific

Block

P00-P04

Parent Code

P04.1

Coding Notes

Includes

Conditions included under this code

  • conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
  • nonteratogenic effects of substances transmitted via placenta

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

  • dysmorphism due to warfarin (Q86.2)
  • fetal hydantoin syndrome (Q86.1)

Excludes 2

Conditions not included here, but the patient may have both

  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • tetanus neonatorum (A33)
  • congenital malformations (Q00-Q99)
  • encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
  • neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
  • newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
  • maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
  • maternal use of drugs of addiction (P04.4-)

Code First

The underlying condition must be sequenced before this code

  • any current condition in newborn, if applicable
  • , if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1)
  • withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)

Also Known As / Clinical Terms

UMLS

Frequently Asked Questions

What is the ICD-10 code for newborn affected by maternal use of anxiolytics?

The ICD-10-CM code for newborn affected by maternal use of anxiolytics is P04.1A. The full clinical description is "Newborn affected by maternal use of anxiolytics". P04.1A is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code P04.1A mean?

ICD-10-CM code P04.1A represents "Newborn affected by maternal use of anxiolytics". It is classified under Chapter 16: Certain Conditions Originating in the Perinatal Period and is a billable/specific code that can be used on a claim.

Is P04.1A a billable code?

Yes, P04.1A is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is P04.1A in?

P04.1A is in Chapter 16: Certain Conditions Originating in the Perinatal Period (codes P00-P96).

What codes cannot be used with P04.1A?

P04.1A has Excludes1 notes indicating codes that cannot be used together with it, including: dysmorphism due to warfarin (Q86.2); fetal hydantoin syndrome (Q86.1).

What are the UMLS CUIs for P04.1A?

P04.1A is linked to 1 UMLS Concept Unique Identifier: C4552731. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Try FreeView API Docs

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.